Mutch DG - Search Results

1

Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.

Hamilton CA, Miller A, Casablanca Y, Horowitz NS, Rungruang B, Krivak TC, Richard SD, Rodriguez N, Birrer MJ, Backes FJ, Geller MA, Quinn M, Goodheart MJ, Mutch DG, Kavanagh JJ, Maxwell GL, Bookman MA. Hamilton CA, et al. Among authors: mutch dg. Gynecol Oncol. 2018 Feb;148(2):275-280. doi: 10.1016/j.ygyno.2017.11.018. Epub 2017 Nov 28. Gynecol Oncol. 2018. PMID: 29195926 Free PMC article. Clinical Trial.

2

The effects of cyclosporin A on the lysis of ovarian cancer cells by cisplatin or adriamycin.

Mutch DG, Herzog TJ, Chen CA, Collins JL. Mutch DG, et al. Gynecol Oncol. 1992 Oct;47(1):28-33. doi: 10.1016/0090-8258(92)90070-y. Gynecol Oncol. 1992. PMID: 1427396

3

In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatin.

Mutch DG, Powell CB, Kao MS, Collins JL. Mutch DG, et al. Gynecol Oncol. 1989 Sep;34(3):328-33. doi: 10.1016/0090-8258(89)90167-4. Gynecol Oncol. 1989. PMID: 2767524

4

Biology of epithelial ovarian cancer.

Mutch DG, Williams S. Mutch DG, et al. Clin Obstet Gynecol. 1994 Jun;37(2):406-22. doi: 10.1097/00003081-199406000-00017. Clin Obstet Gynecol. 1994. PMID: 8033452 Review. No abstract available.

5

Correlates of length of stay in gynecologic oncology patients undergoing inpatient surgery.

Massad LS, Vogler G, Herzog TJ, Mutch DG. Massad LS, et al. Among authors: mutch dg. Gynecol Oncol. 1993 Nov;51(2):214-8. doi: 10.1006/gyno.1993.1275. Gynecol Oncol. 1993. PMID: 8276297

6

Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.

Arlt MF, Herzog TJ, Mutch DG, Goodfellow PJ. Arlt MF, et al. Among authors: mutch dg. Gynecol Oncol. 1996 Feb;60(2):308-12. doi: 10.1006/gyno.1996.0044. Gynecol Oncol. 1996. PMID: 8631557

7

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.

Ball HG, Blessing JA, Lentz SS, Mutch DG. Ball HG, et al. Among authors: mutch dg. Gynecol Oncol. 1996 Aug;62(2):278-81. doi: 10.1006/gyno.1996.0227. Gynecol Oncol. 1996. PMID: 8751561 Clinical Trial.

8

Topotecan in platinum- and paclitaxel-resistant ovarian cancer.

Swisher EM, Mutch DG, Rader JS, Elbendary A, Herzog TJ. Swisher EM, et al. Among authors: mutch dg. Gynecol Oncol. 1997 Sep;66(3):480-6. doi: 10.1006/gyno.1997.4787. Gynecol Oncol. 1997. PMID: 9299264 Clinical Trial.

9

Factors predicting subcutaneous implanted central venous port function: the relationship between catheter tip location and port failure in patients with gynecologic malignancies.

Cohn DE, Mutch DG, Rader JS, Farrell M, Awantang R, Herzog TJ. Cohn DE, et al. Among authors: mutch dg. Gynecol Oncol. 2001 Dec;83(3):533-6. doi: 10.1006/gyno.2001.6433. Gynecol Oncol. 2001. PMID: 11733967

10

Epithelial ovarian tumors of low malignant potential: the role of microinvasion.

Buttin BM, Herzog TJ, Powell MA, Rader JS, Mutch DG. Buttin BM, et al. Among authors: mutch dg. Obstet Gynecol. 2002 Jan;99(1):11-7. doi: 10.1016/s0029-7844(01)01675-1. Obstet Gynecol. 2002. PMID: 11777503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters